Get the Stockscreener App
9.25
6.75%
-0.67
After Hours:
9.43
0.18
+1.95%
Kodiak Sciences Inc stock is traded at $9.25, with a volume of 373.11K.
It is down -6.75% in the last 24 hours and up +8.57% over the past month.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
See More
Previous Close:
$9.92
Open:
$9.85
24h Volume:
373.11K
Relative Volume:
0.71
Market Cap:
$488.60M
Revenue:
-
Net Income/Loss:
$-197.68M
P/E Ratio:
-2.4601
EPS:
-3.76
Net Cash Flow:
$-158.88M
1W Performance:
-12.07%
1M Performance:
+8.57%
6M Performance:
+143.42%
1Y Performance:
+288.66%
1-Day Range:
$8.91
$9.92
1-Week Range:
$8.91
$10.62
52-Week Range:
$1.92
$11.60
Kodiak Sciences Inc Stock (KOD) Company Profile
Name
Kodiak Sciences Inc
Sector
Industry
Phone
650-281-0850
Address
1200 PAGE MILL RD, PALO ALTO, CA
Compare KOD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
9.25 | 513.69M | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-09-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-05-24 | Initiated | H.C. Wainwright | Neutral |
| Dec-11-23 | Resumed | Goldman | Sell |
| Nov-17-23 | Upgrade | CapitalOne | Equal Weight → Overweight |
| Jul-27-23 | Downgrade | UBS | Buy → Neutral |
| Jul-25-23 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-25-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-24-23 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jul-24-23 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-22 | Initiated | CapitalOne | Overweight |
| Aug-02-22 | Downgrade | Citigroup | Neutral → Sell |
| Feb-24-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-21 | Upgrade | ROTH Capital | Neutral → Buy |
| Mar-12-21 | Initiated | Evercore ISI | Outperform |
| Mar-01-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-17-21 | Downgrade | ROTH Capital | Buy → Neutral |
| Jan-25-21 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-17-20 | Initiated | Berenberg | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Nov-30-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-13-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-31-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-03-20 | Initiated | Goldman | Buy |
| Feb-18-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-06-20 | Initiated | SunTrust | Buy |
| Jan-08-20 | Initiated | ROTH Capital | Buy |
| Jan-03-20 | Initiated | Jefferies | Buy |
| Dec-24-19 | Initiated | JP Morgan | Overweight |
| Oct-15-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-20-19 | Initiated | Chardan Capital Markets | Buy |
| Oct-29-18 | Initiated | Barclays | Overweight |
| Oct-29-18 | Initiated | BofA/Merrill | Buy |
| Oct-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Kodiak Sciences Inc Stock (KOD) Latest News
Analyzing Kodiak Sciences Inc. with risk reward ratio chartsGlobal Markets & High Conviction Trade Alerts - Newser
Analyzing Kodiak Sciences Inc. with multi timeframe chartsQuarterly Growth Report & Stock Timing and Entry Methods - Newser
What does recent volatility data suggest for Kodiak Sciences Inc.Treasury Yields & Stepwise Trade Signal Guides - Newser
What to expect from Kodiak Sciences Inc. in the next 30 days2025 Earnings Impact & Capital Protection Trading Alerts - Newser
Applying chart zones and confluence areas to Kodiak Sciences Inc.Quarterly Market Summary & Risk Controlled Stock Pick Alerts - Newser
Does Kodiak Sciences Inc. qualify in momentum factor screening2025 Buyback Activity & Verified Short-Term Trading Plans - Newser
Is now a turning point for Kodiak Sciences Inc.Market Sentiment Report & Growth Focused Stock Reports - Newser
Market reaction to Kodiak Sciences Inc.’s recent newsJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Invesco Ltd. Has $227,000 Stake in Kodiak Sciences Inc. $KOD - MarketBeat
Risk adjusted return profile for Kodiak Sciences Inc. analyzedJuly 2025 Fed Impact & Weekly Setup with ROI Potential - Newser
What MACD and RSI say about Kodiak Sciences Inc.Share Buyback & High Accuracy Trade Alerts - Newser
Why Is Kodiak Sciences (KOD) Down 1.2% Since Last Earnings Report? - Nasdaq
Kodiak Sciences Inc. stock prediction for this weekRecession Risk & Real-Time Market Trend Scan - Newser
Adage Capital Partners GP L.L.C. Grows Stock Holdings in Kodiak Sciences Inc. $KOD - MarketBeat
Will breakout in Kodiak Sciences Inc. lead to full recoveryMarket Risk Report & Risk Managed Investment Strategies - Newser
Technical analysis overview for Kodiak Sciences Inc. stockJuly 2025 PostEarnings & Weekly Market Pulse Alerts - Newser
Has Kodiak Sciences Inc. found a price floorJuly 2025 Earnings & Smart Investment Allocation Insights - Newser
Short interest data insights for Kodiak Sciences Inc.Quarterly Trade Summary & Growth Focused Entry Point Reports - Newser
Will Kodiak Sciences Inc. benefit from macro trendsPortfolio Gains Report & Daily Risk Controlled Trade Plans - Newser
Will a bounce in Kodiak Sciences Inc. offer an exitPortfolio Risk Summary & Low Drawdown Trading Techniques - Newser
Long term hold vs stop loss in Kodiak Sciences Inc.Earnings Overview Report & Free Technical Pattern Based Buy Signals - Newser
Developing predictive dashboards with Kodiak Sciences Inc. dataMarket Rally & Weekly Stock Performance Updates - Newser
Kodiak Sciences Q3 EPS Estimate Reduced by Zacks Research - MarketBeat
Custom strategy builders for tracking Kodiak Sciences Inc.Weekly Market Outlook & Target Return Focused Stock Picks - Newser
Is Kodiak Sciences Inc. stock entering bullish territoryJuly 2025 Retail & Short-Term Trading Alerts - Newser
Applying Wyckoff theory to Kodiak Sciences Inc. stockJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - Newser
Advanced analytics toolkit walkthrough for Kodiak Sciences Inc.2025 Market Trends & Fast Entry High Yield Stock Tips - Newser
Volume spikes in Kodiak Sciences Inc. stock – what they meanJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - Newser
Nuveen LLC Acquires Shares of 139,688 Kodiak Sciences Inc. $KOD - MarketBeat
Combining machine learning predictions for Kodiak Sciences Inc.Portfolio Value Summary & Accurate Intraday Trade Tips - Newser
Is Kodiak Sciences Inc. forming a reversal pattern2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Technical signs of recovery in Kodiak Sciences Inc.Forecast Cut & Technical Pattern Recognition Alerts - Newser
Price action breakdown for Kodiak Sciences Inc.Weekly Trade Report & Safe Capital Growth Trade Ideas - Newser
Kodiak Sciences Inc Stock (KOD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):